Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Paper Strip Test Could Replace Current Pancreatic Cancer Tests

By LabMedica International staff writers
Posted on 23 Jul 2012
A new approach to clinical laboratory testing could eliminate the need for tissue biopsies to diagnose different types of cancer.

A 15-year-old high school student developed a diagnostic assay that experts say can be developed into medical laboratory test for the detection of pancreatic cancer. More...
The teen’s prize-winning breakthrough test could change how cancer and other fatal diseases are diagnosed and treated.

The new approach to detecting pancreatic cancer is noninvasive, so it does not require a biopsy specimen. It is also inexpensive and fast. At a cost of about USD 3 per test, the diagnostic assay produces a result in five minutes. The detection device was a USD 50 electric meter from a home ware store. The student observed that this diagnostic test would also work with an ordinary diabetes meter.

The student, Jack Andraka, created a clinical laboratory test that uses filter paper dipped into a solution of carbon nanotubes (CN). It detects the levels of mesothelin in blood or urine. Mesothelin is a protein biomarker for pancreatic cancer

“It’s really crucial to detect [pancreatic, lung, and ovarian cancers] in their early stages where survival rates are at their highest,” Jack Andraka declared. “I focused specifically on pancreatic cancer […] due to its extremely low survival rates.”

The test can be adapted to monitor resistance to antibiotics and to follow the progression of treatment of cancer patients undergoing chemotherapy or radiation.

Related Links:

National Cancer Institute




New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Serological Pipet Controller
PIPETBOY GENIUS
New
Pipette
Accumax Smart Series
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.